These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 7889203
1. Renal protective effects of angiotensin II receptor I antagonist CV-11974 in spontaneously hypertensive stroke-prone rats (SHR-sp). Nakamura T, Honma H, Ikeda Y, Kuroyanagi R, Takano H, Obata J, Sato T, Kimura H, Yoshida Y, Tamura K. Blood Press Suppl; 1994; 5():61-6. PubMed ID: 7889203 [Abstract] [Full Text] [Related]
2. Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats. Matsumoto K, Morishita R, Moriguchi A, Tomita N, Yo Y, Nishii T, Nakamura T, Higaki J, Ogihara T. Hypertension; 1999 Aug; 34(2):279-84. PubMed ID: 10454454 [Abstract] [Full Text] [Related]
3. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats. Chung S, Park CW, Shin SJ, Lim JH, Chung HW, Youn DY, Kim HW, Kim BS, Lee JH, Kim GH, Chang YS. Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146 [Abstract] [Full Text] [Related]
4. Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Wada T, Ishimura Y, Chatani F. Blood Press Suppl; 1994 Feb; 5():54-6. PubMed ID: 7889201 [Abstract] [Full Text] [Related]
5. Involvement of angiotensin II in glomerulosclerosis of stroke-prone spontaneously hypertensive rats. Nakamura T, Obata J, Kuroyanagi R, Kimura H, Ikeda Y, Takano H, Naito A, Sato T, Yoshida Y. Kidney Int Suppl; 1996 Jun; 55():S109-12. PubMed ID: 8743527 [Abstract] [Full Text] [Related]
6. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury. Ishiguro K, Sasamura H, Sakamaki Y, Itoh H, Saruta T. Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373 [Abstract] [Full Text] [Related]
7. Nonpeptide angiotensin II type 1 receptor antagonist prevents nephrosclerosis in hypertensive rats. Kanno Y, Okada H, Suzuki H, Ikenaga H, Saruta T. Blood Press Suppl; 1994 Jan; 5():67-70. PubMed ID: 7889204 [Abstract] [Full Text] [Related]
8. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders. Watanabe D, Tanabe A, Naruse M, Morikawa S, Ezaki T, Takano K. Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019 [Abstract] [Full Text] [Related]
9. Changes in angiotensin receptors expression play a pivotal role in the renal damage observed in spontaneously hypertensive rats. Landgraf SS, Wengert M, Silva JS, Zapata-Sudo G, Sudo RT, Takiya CM, Pinheiro AA, Caruso-Neves C. Am J Physiol Renal Physiol; 2011 Feb; 300(2):F499-510. PubMed ID: 21084406 [Abstract] [Full Text] [Related]
10. Superoxide dismutase mimetic, tempol, aggravates renal injury in advanced-stage stroke-prone spontaneously hypertensive rats. Sugama I, Kohagura K, Yamazato M, Nakamura T, Shinzato T, Ohya Y. J Hypertens; 2014 Mar; 32(3):534-41. PubMed ID: 24309490 [Abstract] [Full Text] [Related]
11. Candesartan prevents the progression of glomerulosclerosis in genetic hypertensive rats. Obata J, Nakamura T, Kuroyanagi R, Yoshida Y, Guo DF, Inagami T. Kidney Int Suppl; 1997 Dec; 63():S229-31. PubMed ID: 9407467 [Abstract] [Full Text] [Related]